Search the Appendices of Resolution CM/Res(2018)1
1932 found
INN | ATC Code | Country | Classification | Last update | MA Number ▲ | Registration date | Status | |
---|---|---|---|---|---|---|---|---|
PEGUNIGALSIDASE ALFA | A16AB20 | SI | POM | 14-11-2023 | EMEA/H/C/005618 | 04-05-2023 | VALID | |
FUTIBATINIB | L01EN04 | SI | Not authorised | 05-05-2025 | EMEA/H/C/005627 | 04-07-2023 | VALID | |
SOTATERCEPT | C02KC06 | SI | Not authorised | 05-05-2025 | EMEA/H/C/005647 | 22-08-2024 | VALID | |
VAMOROLONE | H02AB18 | SI | POM | 13-05-2024 | EMEA/H/C/005679 | 14-12-2023 | VALID | |
LONCASTUXIMAB TESIRINE | L01FX22 | SI | POM | 18-08-2023 | EMEA/H/C/005685 | 20-12-2022 | VALID | |
CATUMAXOMAB | L01FX03 | SI | POM | 05-05-2025 | EMEA/H/C/005697 | 10-02-2025 | VALID | |
BEVACIZUMAB | S01LA08 | SI | Not authorised | 05-05-2025 | EMEA/H/C/005723 | 27-05-2024 | VALID | |
GLOFITAMAB | L01FX28 | SI | POM | 14-11-2023 | EMEA/H/C/005751 | 07-07-2023 | VALID | |
DEUCRAVACITINIB | L04AF07 | SI | POM | 18-08-2023 | EMEA/H/C/005755 | 24-03-2023 | VALID | |
EXAGAMGLOGENE AUTOTEMCEL | B06AX05 | SI | Not authorised | 05-05-2025 | EMEA/H/C/005763 | 09-02-2024 | VALID | |
IPTACOPAN | L04AJ08 | SI | POM | 22-10-2024 | EMEA/H/C/005764 | 17-05-2024 | VALID | |
MOMELOTINIB | L01EJ04 | SI | Not authorised | 05-05-2025 | EMEA/H/C/005768 | 25-01-2024 | VALID | |
TRASTUZUMAB | L01XC03 | SI | Not authorised | 05-05-2025 | EMEA/H/C/005769 | 15-11-2023 | VALID | |
SUTIMLIMAB | L04AJ04 | SI | POM | 18-08-2023 | EMEA/H/C/005776 | 15-11-2022 | VALID | |
SPARSENTAN | C09XX01 | SI | POM | 22-10-2024 | EMEA/H/C/005783 | 19-04-2024 | VALID | |
MARIBAVIR | J05AX10 | SI | POM | 18-08-2023 | EMEA/H/C/005787 | 09-11-2022 | VALID | |
CHIKUNGUNYA VACCINES | J07BX07 | SI | POM | 05-05-2025 | EMEA/H/C/005797 | 28-06-2024 | VALID | |
ROZANOLIXIZUMAB | L04AG16 | SI | Not authorised | 05-05-2025 | EMEA/H/C/005824 | 05-01-2024 | VALID | |
GANAXOLONE | N03AX27 | SI | Not authorised | 05-05-2025 | EMEA/H/C/005825 | 26-07-2023 | VALID | |
RUXOLITINIB | D11AH09 | SI | POM | 18-08-2023 | EMEA/H/C/005843 | 19-04-2023 | VALID | |
FEZOLINETANT | G02CX06 | SI | POM | 13-05-2024 | EMEA/H/C/005851 | 07-12-2023 | VALID | |
MARALIXIBAT CHLORIDE | A05AX04 | SI | POM | 18-08-2023 | EMEA/H/C/005857 | 09-12-2022 | VALID | |
ZOLBETUXIMAB | L01FX31 | SI | POM | 22-10-2024 | EMEA/H/C/005868 | 19-09-2024 | VALID | |
ATOGEPANT | N02CD07 | SI | POM | 14-11-2023 | EMEA/H/C/005871 | 11-08-2023 | VALID | |
SPESOLIMAB | L04AC22 | SI | POM | 18-08-2023 | EMEA/H/C/005874 | 09-12-2022 | VALID | |
LEBRIKIZUMAB | D11AH10 | SI | Not authorised | 05-05-2025 | EMEA/H/C/005894 | 16-11-2023 | VALID | |
REZAFUNGIN | J02AX08 | SI | Not authorised | 05-05-2025 | EMEA/H/C/005900 | 22-12-2023 | VALID | |
ELRANATAMAB | L01FX32 | SI | POM | 13-05-2024 | EMEA/H/C/005908 | 07-12-2023 | VALID | |
QUIZARTINIB | L01EX11 | SI | Not authorised | 05-05-2025 | EMEA/H/C/005910 | 06-11-2023 | VALID | |
UBLITUXIMAB | L04AG14 | SI | POM | 14-11-2023 | EMEA/H/C/005914 | 31-05-2023 | VALID | |
TISLELIZUMAB | L01FF09 | SI | POM | 14-11-2023 | EMEA/H/C/005919 | 15-09-2023 | VALID | |
PALOPEGTERIPARATIDE | H05AA05 | SI | POM | 13-05-2024 | EMEA/H/C/005934 | 17-11-2023 | VALID | |
IVOSIDENIB | L01XM02 | SI | POM | 14-11-2023 | EMEA/H/C/005936 | 04-05-2023 | VALID | |
CONCIZUMAB | B02BX10 | SI | POM | 05-05-2025 | EMEA/H/C/005938 | 13-12-2024 | VALID | |
VIBEGRON | G04BD15 | SI | Not authorised | 05-05-2025 | EMEA/H/C/005957 | 27-06-2024 | VALID | |
EFANESOCTOCOG ALFA | B02BD02 | SI | POM | 22-10-2024 | EMEA/H/C/005968 | 17-06-2024 | VALID | |
NIRMATRELVIR AND RITONAVIR | J05AE30 | SI | POM | 18-08-2023 | EMEA/H/C/005973 | 28-01-2022 | VALID | |
INSULIN ICODEC | A10AE07 | SI | POM | 22-10-2024 | EMEA/H/C/005978 | 17-05-2024 | VALID | |
FRUQUINTINIB | L01EK04 | SI | POM | 22-10-2024 | EMEA/H/C/005979 | 20-06-2024 | VALID | |
REPOTRECTINIB | L01EX28 | SI | POM | 05-05-2025 | EMEA/H/C/006005 | 13-01-2025 | VALID | |
ETRASIMOD | L04AE05 | SI | POM | 13-05-2024 | EMEA/H/C/006007 | 16-02-2024 | VALID | |
DANTROLENE | M03CA01 | SI | Not authorised | 05-05-2025 | EMEA/H/C/006009 | 29-05-2024 | VALID | |
ADAGRASIB | L01XX77 | SI | Not authorised | 05-05-2025 | EMEA/H/C/006013 | 05-01-2024 | VALID | |
CAPIVASERTIB | L01EX27 | SI | POM | 22-10-2024 | EMEA/H/C/006017 | 17-06-2024 | VALID | |
RITLECITINIB | L04AF08 | SI | POM | 14-11-2023 | EMEA/H/C/006025 | 15-09-2023 | VALID | |
RESPIRATORY SYNCYTIAL VIRUS VACCINES | J07BX05 | SI | POM | 14-11-2023 | EMEA/H/C/006027 | 23-08-2023 | VALID | |
DOPAMINE | C01CA04 | SI | POM | 22-10-2024 | EMEA/H/C/006044 | 27-05-2024 | VALID | |
ERDAFITINIB | L01EN01 | SI | POM | 06-05-2025 | EMEA/H/C/006050 | 22-08-2024 | VALID | |
INFLUENZA VACCINE (SURFACE ANTIGEN, INACTIVATED, PREPARED IN CELL CULTURES) | J07BB02 | SI | POM | 22-10-2024 | EMEA/H/C/006051 | 19-04-2024 | VALID | |
CROVALIMAB | L04AJ07 | SI | POM | 22-10-2024 | EMEA/H/C/006061 | 22-08-2024 | VALID |